113 — New York, New York

113 is a clinical research site located in New York, New York, United States 22042.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

113 has participated in 1 clinical trials.

Therapeutic areas: Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection.

Sponsors: Zambon SpA.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 113?

113 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 113 conducted?

113 has 1 clinical trials on record. Their work covers Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection.

Is 113 accredited by Crixeo Health?

113 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 113?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.